Autonomous EPO production is a reported cause of secondary polycythemia in a variety of malignant tumors, including renal cell carcinoma, meningioma, and hepatocellular carcinoma [6,9,[11], [12], [13], [14], [15], [16]]. This evidence concerns the gene EPO and cancer.